An IκB Kinase-Regulated Feedforward Circuit Prolongs Inflammation  by Perez, Jessica M. et al.
ReportAn IkB Kinase-Regulated Feedforward Circuit
Prolongs InflammationGraphical AbstractHighlightsd IKKs phosphorylate ITCH in a highly conserved region of the
HECT domain
d E3 ubiquitin ligase activity is impaired in IKK-phosphorylated
ITCH
d Impaired ITCH results in heightened TNF signaling
d Activated IKKs can affect multiple pathways through
inhibitory ITCH phosphorylationPerez et al., 2015, Cell Reports 12, 537–544
July 28, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.06.050Authors
Jessica M. Perez, Steven M. Chirieleison,
Derek W. Abbott
Correspondence
dwa4@case.edu
In Brief
Perez et al. utilize a proteomic/
bioinformatic approach to identify ITCH,
an E3 ubiquitin ligase, as a substrate of
IKK. ITCH phosphorylation decreases its
ability to inhibit signaling and leads to
exaggerated cytokine responses.
Genetically, this manifests as a delay in
ITCH-induced pulmonary inflammation
upon loss of TNF signaling.
Cell Reports
ReportAn IkB Kinase-Regulated Feedforward
Circuit Prolongs Inflammation
Jessica M. Perez,1 Steven M. Chirieleison,1 and Derek W. Abbott1,*
1Department of Pathology, Case Western Reserve University (CWRU) School of Medicine, Cleveland, OH 44106, USA
*Correspondence: dwa4@case.edu
http://dx.doi.org/10.1016/j.celrep.2015.06.050
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARY
Loss of NF-kB signaling causes immunodeficiency,
whereas inhibition of NF-kB can be efficacious in
treating chronic inflammatory disease. Inflammatory
NF-kB signaling must therefore be tightly regulated,
and although many mechanisms to downregulate
NF-kB have been elucidated, there have only been
limited studies demonstrating positive feedforward
regulation of NF-kB signaling. In this work, we use
a bioinformatic and proteomic approach to discover
that the IKK family of proteins can phosphorylate the
E3 ubiquitin ligase ITCH, a critical downregulator of
TNF-mediated NF-kB activation. Phosphorylation of
ITCH by IKKs leads to impaired ITCH E3 ubiquitin
ligase activity and prolongs NF-kB signaling and
pro-inflammatory cytokine release. Since genetic
loss of ITCH mirrors IKK-induced ITCH phosphoryla-
tion, we further show that the ITCH/mouse’s spon-
taneous lung inflammation and subsequent death
can be delayed when TNF signaling is genetically
deleted. This work identifies a new positive feedfor-
ward regulation of NF-kB activation that drives in-
flammatory disease.
INTRODUCTION
Inflammatory signaling pathways are among the most tightly
regulated in the body. Inflammatory responses must be strong
enough to combat pathogens, but they also must be measured
to avoid unnecessary host damage. As a major driver of inflam-
matory signaling, NF-kB transcriptional activation is a prime
example of such tight pathway regulation. Although the main
products of classically activated NF-kB include potent cytokines
and chemokines, the initial NF-kB transcriptional program also is
designed to limit NF-kB activity (Hayden and Ghosh, 2012).
Negative feedback proteins such as IkBa and A20 are among
the first NF-kB-driven genes transcribed (Krikos et al., 1992;
Shembade and Harhaj, 2012; Sun et al., 1993). However, tran-
scriptional reprogramming takes time, and a more a rapid
response is essential to properly tailor the strength and duration
of inflammation (Perkins, 2006). To this end, posttranslational
modifications such as phosphorylation and ubiquitination can
quickly alter cellular activity for tight signaling regulation (Hunter,2007; Tigno-Aranjuez et al., 2013). Posttranslational modifiers,
such as kinases and ubiquitin ligases, can quickly change the ac-
tivity of enzymes, affect localization of proteins, alter stability in
regard to degradation, and promote interaction of diverse pro-
teins to fine-tune signaling, such that the body can eradicate
an offending pathogen while also limiting host damage (Gal-
lagher et al., 2006; Prabakaran et al., 2012).
As a central hub for the NF-kB signaling pathway, the IkB ki-
nases (IKKs) are positioned to provide such a rapid response.
Although being most famous for the phosphorylation of the IkB
proteins to activate the NF-kB transcription factors (Chen
et al., 1996), they also now are recognized to be fast activators
of feedback inhibition of this pathway. For example, IKKa phos-
phorylates TRAF4 to promote its stability and activity as an inhib-
itor of NOD2-mediated NF-kB (Marinis et al., 2012). IKKa also
phosphorylates TAX1BP1 to recruit A20, RNF11, and ITCH, al-
lowing formation of a ubiquitin-remodeling complex that down-
regulates TNF-mediated NF-kB activation (Shembade et al.,
2008, 2011). Similarly, IKKb phosphorylates A20 to promote
downregulation of NF-kB by enhancing its deubiquitination func-
tion (Hutti et al., 2007). However, this rapid response is not
limited to feedback inhibition (Liu et al., 2012). It has been shown
recently that IKKb can phosphorylate IRF5 to induce an inter-
feron response (Lopez-Pelaez et al., 2014; Ren et al., 2014),
and it is also known that NF-kB can undergo a positive feedfor-
ward regulation through the paracrine and autocrine expression
of IL-17 and IL-6 (Ogura et al., 2008). Thus, identification of novel
IKK phosphorylation sites and study of the regulation of those
sites continue to help us understand inflammatory responses.
Given this, we hypothesized that there are additional IKK sub-
strates that might prolong NF-kB signaling. We therefore devel-
oped a dual bioinformatic/proteomic approach to rapidly identify
novel substrates of the IKKs. Coupling data from peptide array
analysis with a novel IKK-substrate motif antibody, we describe
an approach to rapidly identify novel IKK substrates. We used
this approach to identify and confirm phosphorylation of a novel
IKK substrate, ITCH, a HECT E3 ubiquitin ligase. ITCH is present
in endolysosomal compartments, an area shown to contain
active IKK complexes, and functions with the E2 ubiquitin ligases
UbcH5, UbcH6, and UbcH7 to catalyze the formation of a wide
variety of polyubiquitin chains, including K11, K29, K48, and
K63-linked polyubiquitination (Angers et al., 2004; Chastagner
et al., 2006; Perry et al., 1998; Shembade et al., 2008; Tao
et al., 2009; Wei et al., 2012). Biologically, ITCH is known to
downregulate a variety of inflammatory signaling pathways,
including the RIG-I/MAVS pathway in antiviral signaling (YouCell Reports 12, 537–544, July 28, 2015 ª2015 The Authors 537
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Figure 1. ITCH Is a Novel Substrate of IKKs
(A) A schematic outline for finding novel IKK substrates is shown. IKK phospho-peptide array data revealed a consensus IKK phosphorylation motif. The motif
generated was used for a Scansite bioinformatic search and coupled with a custom antibody generated against the phosphorylated motif; ITCHwas identified as
a candidate IKK substrate.
(B) Recombinant ITCH was subjected to 32P in vitro kinase assay with recombinant IKKa and IKKb in separate experiments. Both IKKa and IKKb could phos-
phorylate ITCH.
(C and D) HEK293 cells were transfected with FLAG-tagged ITCH or C830A (catalytically inactive ITCH) and either active or kinase-inactive IKKa (C, upper blots),
active IKKb or kinase-inactive IKKb (C, lower blots), active or inactive IKKε, or active or inactive TBK1 (D). All IKK family members caused ITCH phosphorylation.
(E and F) Jurkat T cells (E) or A549 lung epithelial cells (F) were treated with TNF-a as indicated. IP of IKK phospho-motif-containing proteins and immunoblotting
were performed. As a control, irrelevant rabbit polyclonal antibody was used (F). Phosphorylation of ITCH matched the time course of IKK activation and IKK
phosphorylation of the known substrates IkBa and p105.et al., 2009), the NOD/RIP2 pathway in intracellular bacterial
signaling (Tao et al., 2009), and TNF-a-mediated NF-kB activa-
tion in inflammatory signaling (Shembade et al., 2008). In this
study, we found that IKK phosphorylation of ITCH inhibits its
ability to downregulate signaling pathways and inhibit cytokine
responses. Lastly, given that TNF is a major activator of IKKs
and that ITCH serves to downregulate TNF signaling, we show
that genetic loss of TNFR1 attenuates the pulmonary inflamma-
tory phenotype of the ITCH/ mice. This paper thus identifies a
novel phosphorylation-dependent signaling cascade that serves
to prolong inflammatory signaling.
RESULTS AND DISCUSSION
IKKs Phosphorylate the HECT E3 Ubiquitin Ligase ITCH
on Serine 687
To identify novel substrates of IKKs using a joint proteomic/bio-
informatic approach, peptide substrate array data from our pre-538 Cell Reports 12, 537–544, July 28, 2015 ª2015 The Authorsvious studies (Hutti et al., 2007, 2009; Marinis et al., 2012) was
used to generate polyclonal antibodies designed against the
preferred IKK phospho-peptide motif (F/Y/M-X-pS-L/I/M) (Hutti
et al., 2007, 2009). We then quantified the relative positively
and negatively selected amino acid preferences from the peptide
substrate array data to generate a matrix such that proteomic
databases could be searched for amino acid sequences match-
ing these phosphorylation motifs (Obenauer et al., 2003). This
paired approach allowed us to identify a large number of poten-
tial substrates via bioinformatic searches, while also allowing us
to quickly screen those substrates through the use of the IKK
phospho-motif antibody. In initial testing, 11 substrates were
screened including the known IKK substrate TANK. Of these
initial substrates tested, positive IKK phosphorylation was iden-
tified for seven substrates. Among these seven substrates,
ITCH, a WW domain-containing HECT E3 ligase family shown
previously by our lab to downregulate the NOD2:RIP2 signaling
pathway, was identified (Figure 1A).
To determine whether the IKKs directly phosphorylate ITCH,
we conducted in vitro kinase assays with g32P-labeled ATP
and recombinant ITCH. 32P transfer by both IKKa and IKKb to
both ITCH and ligase-dead (C830A) ITCH was detected, indi-
cating direct phosphorylation by IKKa and IKKb that did not
require the catalytic activity of ITCH (Figure 1B; generation of re-
combinant bacterial ITCH and variants is shown in Figure S1A).
Furthermore, co-transfection of ITCH or C830A ITCH with IKKa
also revealed phosphorylation of ITCH, but did require the C2
domain and subsequent membrane localization of ITCH (Fig-
ure 1C, upper blots). IKKb and kinase inactive K44A IKKb also
were tested and showed similar results (Figure 1C, lower blots).
Additionally, as the IKK-related kinases IKKε and TBK1 share
similarities in kinase structure and preferred phosphorylation
motif (Hutti et al., 2009, 2012), both of these kinases induced
phosphorylation of ITCH (Figure 1D). Thus, all four IKKs phos-
phorylate ITCH.
We further investigated IKK-mediated phosphorylation of
ITCH in an endogenous setting. ITCH is known to have a strong
function in T cells (Jin et al., 2013). For this reason, Jurkat T cells
were treated with TNF. Samples were collected at the indicated
time points and the IKK substrate antibody was used to immuno-
precipitate proteins containing the phosphomotif. Probing for
ITCH revealed the presence of phosphorylated ITCH that corre-
lated bothwith IKK activation andwith the phosphorylation of the
known IKK substrates p105 and IkBa (Figure 1E). Similarly, treat-
ment of the lung epithelial cell line A549 showed TNF-inducible
phosphorylation of endogenous ITCH (Figure 1F). Inhibiting
both IKKa and IKKb through the CRISPR-mediated deletion of
the IKK scaffolding protein, NEMO, showed a loss of TNF-
induced ITCH phosphorylation (Figure S1B). This IKK-induced
phosphorylation can be detected in an endogenous setting,
and, in the case of TNF, is likely mediated by the IKKa/IKKb/
NEMO scaffolding complex.
To determine whether the predicted phosphoacceptor on
ITCH corresponded to the actual phosphoacceptor, we immu-
nopurified IKK-phosphorylated ITCH from Flag-tag ITCH-trans-
fected cells. Purified ITCH was subjected to mass spectrometric
analysis (Figure 2A); 251 peptides were analyzed encompassing
69% of the amino acids of ITCH. Phosphorylation occurred on
33% of peptides containing S687 (DLESIDPEFYNpSLIWVK).
Mass spectrometric sequence analysis also identified an addi-
tional phosphoacceptor (S13) occurring within an IKK peptide
motif (F/Y/M-X-pS-L/I/M). To further determine which of these
two sites was detected by our IKK phospho-substrate antibody,
site-directed mutagenesis was employed. While single muta-
tions did not result in a loss of detected phosphorylation, we
found that mutation of both sites (S13A/S687A ITCH) abolished
the signal (Figure 2B). To differentiate the importance of these
two potential phosphorylation sites, we conducted further seq-
uence analysis and molecular modeling. Although S687 was
conserved through zebrafish, S13A was not conserved (Fig-
ure 2C). Molecular modeling showed that Ser 687 lies within
the N-terminal lobe of the HECT domain. This region of the
HECT domain is known tomake contact with E2-conjugating en-
zymes (Hatakeyama et al., 1997), and this region of ITCH has
been reported to make contact with the E2 ubiquitin ligase
UBCH7 (Ingham et al., 2004; Schwarz et al., 1998). These find-ings lead to the testable hypothesis that IKK-mediated phos-
phorylation of ITCH on S687 affects its E3 ubiquitin ligase activ-
ity, while phosphorylation of S13 does not.
Ubiquitin Ligase Activity and Downstream Signaling Is
Modulated in an ITCH S687D Phosphomimetic Mutant
To determine the effect of Ser 687 phosphorylation on ITCH’s
E3 ligase activity, we generated a phosphomimetic mutant
and used this mutant to perform in vitro ubiquitination assays.
Multi-ubiquitin chains were detected in the presence of wild-
type (WT) ITCH, whereas no ubiquitin chains were detected in
the presence of either ligase-dead C830A ITCH or phosphomi-
metic S687D ITCH (Figure 3A), suggesting that this phosphor-
ylation site might negatively influence ITCH’s E3 ubiquitin ligase
activity. We then performed cellular ubiquitination assays.
HEK293 cells were transiently transfected with HA-tagged
ubiquitin and ITCH variants as indicated. Lysates were gener-
ated and ITCH was immunoprecipitated. Western blotting indi-
cated that both ITCH and S687A ITCH could autoubiquitinate,
while S687D ITCH or ligase-dead C830A ITCH could not (Fig-
ure 3B). To then test whether ITCH has impaired ubiquitin
ligase activity on known substrates, we performed substrate
ubiquitin assays with two known substrates of ITCH, DVL2
and RIP2. ITCH variants were co-transfected with HA-Ubiquitin
and Omni-tagged RIP2 or DVL2 in separate experiments.
ITCH and S687A ITCH were shown to have similar ubiquitina-
tion activity on both RIP2 and DVL2. Catalytically inactive
C830A ITCH and phosphomimetic S687D ITCH showed greatly
reduced ubiquitin chains on both of these proteins (Figures 3C
and 3D, upper blots). In a similar experiment without the addi-
tion of HA-ubiquitin, ITCH and S687A ITCH catalyzed the for-
mation of ubiquitin chains using endogenous ubiquitin, while
again S687D and C830A showed greatly reduced ubiquitination
of RIP2 (Figure S2).
Both the TNF pathway and the WNT/b-catenin pathway are
known to be downregulated by ITCH (Shembade et al., 2008;
Wei et al., 2012). To determine the role of ITCH phosphoryla-
tion on these pathways, luciferase assays were performed
with NF-kB and TCF/LEF reporter constructs. TNF-a and
WNT gene expression activity were strongly reduced with
increasing amounts of ITCH, but they remained largely unaf-
fected in the presence of S687D ITCH (Figure 3D). Compara-
ble experiments were performed to investigate the effect of
phosphorylation at the S13 phosphomotif of ITCH; however,
no differences were detected (Figures S3A and S3B). Like-
wise, an ITCH construct lacking the C2 domain and, therefore,
lacking the ability to be phosphorylated had no effect on TNF-
induced NF-kB activation (Figure S3C). Taken together, these
findings suggest that the IKKs phosphorylate ITCH at residue
S687 to inhibit ITCH’s ability to downregulate signaling
pathways.
ITCH Phosphorylation Causes Increased TNF-Induced
Pro-inflammatory Cytokine Release, and Loss of TNF
Signaling Delays the Pulmonary Inflammatory
Phenotype in ITCH/ Mice
To further investigate the downstream effects of phosphorylation
at S687, ITCH expression was stably inhibited through smallCell Reports 12, 537–544, July 28, 2015 ª2015 The Authors 539
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Figure 2. ITCH Is Phosphorylated on Ser 687
(A) ITCH was co-transfected with IKKb and immunopurified. Phosphorylated ITCH was excised from the Coomassie-stained gel and analyzed by mass spec-
trometry; 251 peptides from ITCH were identified with 69% coverage obtained. Time-of-flight histogram shows a mass-to-charge shift in 33% of peptides
DLESIDPEFYNpSLIWVK, indicating phosphorylation at residue Ser 687.
(B) HEK293 cells were co-transfected with IKKb and each of the following ITCH variants:WT, S13A, S687A, and S13A/S687A.Mutation of both Ser 13 and Ser 687
abolished the phosphorylation signal in the presence of IKKb.
(C) Sequence alignment indicates conservation of S687 in zebrafish, while S13 is not conserved.
(D) The HECT domain’s predicted molecular structure is shown with Ser 687 highlighted. Ser 687 lies within the N-terminal lobe of the HECT domain.hairpin RNA (shRNA) knockdown in A549 cells (Figure 4A, left).
These cells were subsequently transduced with RNAi-resistant
lentiviral FLAG-tagged ITCH variants using mutagenesis of the
third nucleotide in a codon in such a way that does not alter
the amino acid sequence (Figure 4A, right). Each reconstituted
cell line was stimulatedwith TNF-a to determine induced expres-
sion of IL-6 and IL-8 (Figure 4B). Levels of IL-6 and IL-8 mRNA
were similarly high in cells with vector only and S687D ITCH,
while they were greatly reduced in cells reconstituted with WT
ITCH.
To then determine whether this finding is true in vivo, a genetic
approach was utilized. ITCH/ mice develop pulmonary inter-
stitial pneumonitis and consolidated peripheral inflammation
of the alveolar space that ultimately leads to their death at
approximately 6–8months of age (Matesic et al., 2008). Because
TNF-mediated phosphorylation of ITCH is functionally similar to
genetic ITCH loss, we hypothesized that unrestrained TNF
signaling might be influencing the inflammatory lung phenotype540 Cell Reports 12, 537–544, July 28, 2015 ª2015 The Authorsin the ITCH/ mice. To test this hypothesis, ITCH/ mice were
bred with TNFR1/ mice to yield ITCH/TNFR1/ mice.
Lungs were harvested from mice aged 2, 4, and 6 months, and
histopathological analysis was performed. Consolidated inflam-
mation was most prominent at the peripheral, pleural alveolar
space in the ITCH/ mice. This was significantly delayed and
decreased in the ITCH/TNFR1/ mice (Figure 4C). WT,
TNFR1/, ITCH/, and ITCH/TNFR1/ lung histology slides
were then blindly scored to indicate differences in histology
scores at 4 and 6 months of age (Figure 4D). ITCH/TNFR1/
showed a significant decrease in lung pathology. To further show
the delay in pathology, mice were aged for up to 300 days and
survival was plotted. ITCH/TNFR1/ mice had significantly
greater survival time compared to ITCH/ mice (Figure 4E,
lower graph). These findings suggest that unrestrained TNF
signaling partially underlies pathology in the ITCH/ mouse.
Coupled with the fact that TNF-activated IKKs phosphorylate
ITCH to halt ITCH’s inhibitory effect on TNF signaling (Figures
A 
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Figure 3. Ubiquitin Ligase Activity and Downstream Signaling Is Modulated in ITCH S687D Phosphomimetic Mutant
(A) Recombinant ITCH, S687D ITCH, and C830A ITCHwere added to a reaction mix that contained Omni-UBCH7, HA-ubiquitin, E1-activating enzyme, and ATP,
as indicated. Reactions were incubated at 37C for 30 min, then subjected to SDS-PAGE and immunoblotting. S687D ITCH showed a loss of ubiquitination
activity that was comparable to the ligase-dead (C830A) ITCH mutant.
(B) HEK293 cells were transfected with FLAG-tagged ITCH, S687D ITCH, S687A ITCH, or C830A ITCH with HA-tagged ubiquitin. Cell lysates were generated.
ITCH was immunoprecipitated and immunoblotting was performed. S687D ITCH showed greatly decreased autoubiquitination activity.
(C) HEK293 cells were transfected with ITCH variants, HA-tagged ubiquitin, and Omni-tagged DVL2 or RIP2 in separate experiments. DVL2 or RIP2 were
immunoprecipitated in each respective experiment and subjected to western blotting. S687D ITCH showed greatly decreased substrate ubiquitination.
(D) HEK293 cells were transfected with NF-kB luciferase and CMV-Renilla reporter constructs with either ITCH or ITCH S687D mutant expression constructs.
After 16 hr, cells were treated with 10 ng/ml TNF-a for 7 hr and harvested for a luciferase assay (upper graph). Separately, HEK293 cells were transfected with
TCF/LEF luciferase and CMV-Renilla reporter constructs with ITCH or S687D ITCH ± DVL2. Cells were harvested for a luciferase assay 24 hr post-transfection.
(Data are represented as mean ± SEM with *p < 0.05.) ITCH could inhibit both TNF and b-catenin signaling, however, this activity was lost in the S687D ITCH
variant.1, 2, and 3), these data suggest a positive feedback loop
centered on ITCH phosphorylation.
As central kinases in inflammatory signaling cascades, the
IKKs are poised to be central regulators of a diverse set of
cellular responses. Through a proteomic/bioinformatic approach
designed to identify novel IKK substrates, we have identified
a novel IKK phosphorylation site on the E3 ubiquitin ligase,
ITCH, which increases the duration of NF-kB signaling. This
phosphorylation site lies in a region of ITCH that is required for
ITCH’s enzymatic activity, and IKK-mediated phosphorylation
of this site greatly decreases ITCH’s E3 ubiquitin ligase
activity. Biochemically, we hypothesize that since S687 is a
conserved residue in the E2-binding region of the HECT domain
of ITCH, phosphorylation may impair E2 binding or limit transfer
of ubiquitin from the E2 ubiquitin complex to the HECT domain of
ITCH.
The WW-HECT domain E3 ubiquitin ligase family, of which
ITCH is a member, is subject to extensive regulation. These fam-
ily members lie in a catalytically inactive state that requires phos-
phorylation or Ca2+ binding by the C2 domain to be activated
(Mund and Pelham, 2009; Wang et al., 2010). Our data suggestthat phosphorylation of S687 is not required to activate ITCH,
but rather to deactivate it. Thus, it is not surprising that the
DC2 domain mutant, a 200+ amino acid deletion mutant that re-
lieves both auto-inhibition and cellular localization, is neither
phosphorylated nor inactivated by the IKKs (Figures 1C and
S3C). More surprising is the fact that a mutant that lacks the abil-
ity to be phosphorylated (S687A) is not hyperactive. This could
be due to a number of factors, including an increased basal
inhibitory state in the mutant and/or a limiting amount of E2 ubiq-
uitin conjugates in the cell, such that the rate of ubiquitin transfer
can’t increase. Additionally, given that Serine-687 is completely
conserved in all WW-HECT family members and lies in an
invariant region of the E2-binding domain, there may be subtle
structural changes that make the E2-HECT interaction less
effective. What is clear is that the activity of this family of proteins
is heavily regulated in the cell and that, when activated, ITCH
downregulates a variety of signaling pathways, including the
WNT signaling pathway and the TNF signaling pathway. This
work adds a new dynamic to the signaling pathway by which
the IKKs can more globally influence diverse signal transduction
cascades.Cell Reports 12, 537–544, July 28, 2015 ª2015 The Authors 541
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Figure 4. Loss of TNFR1 Partially Complements the Inflammatory Phenotype in ITCH/ Mice
(A) A549 cells were stably transduced with lentiviral shRNA constructs directed against ITCH. ITCH shRNA1 cell lines were then stably reconstituted with vector
only or RNAi-resistant FLAG-ITCH and FLAG-S687D ITCH retroviral constructs. Western blots show both ITCH expression knockdown as well as reconstitution.
(B) Reconstituted ITCH shRNA1 cells were stimulated with 10 ng/ml TNF-a for the indicated times. RNAwas isolated and subjected to qRT-PCR to determine IL-6
and IL-8 gene expression. (Data are represented as mean ± SEM with *p < 0.05.)
(C) Representative images of ITCH/ and ITCH/TNFR1/ lung histology at the pleural surface at 2, 4, and 6 months of age. While the ITCH/mouse shows
significant distal inflammation, consolidation, and chronic inflammation, the TNFR1/ITCH/ mouse shows a significant delay in lung pathology.
(D) Histopathology of the lungs was blindly scored at 4 (WT, n = 4; TNFR1/, n = 4; ITCH/, n = 7; and ITCH/TNFR1/, n = 5) and 6 (WT, n = 4; TNFR1/,
n = 4; ITCH/, n = 5; and ITCH/TNFR1/, n = 6) months. TNFR1/ITCH/ mice show significantly less lung pathology.
(E) Survival of the mice was plotted on a Kaplan-Meier curve (ITCH/, n = 24; ITCH/TNFR1/, n = 22; and TNFR1/, n = 22). Survival time varied significantly
between ITCH/ mice and ITCH/TNFR1/ mice (median survival ratio = 0.6863; log-rank p value of 0.0009).EXPERIMENTAL PROCEDURES
Cell Culture, Transient Transfection, Immunoprecipitation, and
Western Blotting
HEK293T, Jurkat, and A549 cells were maintained in DMEM containing 10%
fetal bovine serum with antibiotic/antimycotic solution (Invitrogen). Calcium
phosphate transfections were carried out as described previously (Abbott
et al., 2004). Cell harvest and immunoprecipitations (IPs) were conducted in
lysis buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton X-100, 1 mM
EGTA, 1 mM EGTA, 2.5 mM sodium orthophosphate, 1 mM b-glycerophos-
phate, 1 mM PMSF, 1 mM Na3VO4, and 10 nM calyculin A in the presence
of protease inhibitor cocktail [Sigma]). Protein G Sepharose beads (Invitrogen)
or FLAG agarose beads were added to lysates for IP. Beads were washed five
times in lysis buffer and boiled in sample buffer prior to western blotting on542 Cell Reports 12, 537–544, July 28, 2015 ª2015 The Authorsnitrocellulose membranes (Bio-Rad), as described previously (Abbott et al.,
2007). Phospho IKK substrate motif polyclonal antibody was generated
against the peptide sequence F/Y/M-X-pS-L/I/M, as described previously
(Hutti et al., 2009). ITCH H110, Actin, and Omni antibodies (Santa Cruz
Biotechnology); glutathione S-transferase (GST), phospho-IKKa/b, DVL2,
phospho-IkBa, IkBa, and phospho-p105 antibodies (Cell Signaling Technol-
ogy); anti-hemagglutinin (HA-11; Covance); anti-Xpress antibody (Invitrogen);
and anti-FLAG antibody and FLAG agarose beads (Sigma-Aldrich) were all
used according to the manufacturers’ directions. 3XFlag DVL2 (WT) was pur-
chased fromAddgene (plasmid 24802) (Narimatsu et al., 2009) andwas placed
in the pcDNA6His Max (Invitrogen) Omni vector using standard restriction
digest. FLAG-ITCH, HA-Ubiquitin, Omni-RIP2, GST-IKKa, GST-IKKaGST-
IKKb, GST-IKKε, GST-TBK1, and mutants were used as described previously
(Hutti et al., 2007, 2009; Tao et al., 2009). Mutant constructs S687D ITCH,
S687A ITCH, and C830A ITCH were generated by QuikChange site-directed
mutagenesis (Stratagene) and verified by sequence analysis. Recombinant
6XHis-UBCH7, GST-ITCH, and GST-ITCH mutants were grown in E. coli and
purified using standard methodology. Recombinant full-length human GST-
IKKa and GST-IKKb were purchased from Millipore. Recombinant HA-Ubiqui-
tin and XP-UBE1 were purchased from Boston Biochem.
In Vitro Kinase Assay
Recombinant GST-ITCH or GST-C830A ITCH was added to GST-IKKa and
10 mCi [g-32P] ATP per reaction. Reaction mix was incubated at 30C for
30 min in kinase buffer (25 mM Tris [pH 7.5], 1 mM b-glycerophosphate,
1 mM DTT, 1 mM Na3VO4, 10 mM MgCl2, and 100 mM ATP). Boiling and
SDS-PAGE were followed by autoradiography.
Mass Spectrometry
Mass spectrometry analysis was performed by the Beth Israel Deaconess
Mass spec core facility under the direction of Dr. John Asara, as described pre-
viously (Tigno-Aranjuez et al., 2010).
In Vitro Ubiquitin Ligase Assay
Recombinant GST-ITCH, GST-ITCH variants, and 6XHis-UbcH7 were purified
as described above, and the reaction was performed as described previously
(Wilkins et al., 2004). Ube1 and HA-Ubiquitin were from Boston Biochem. The
reaction was stopped by the addition of 23 sample buffer and boiling, followed
by SDS-PAGE and immunoblotting.
Luciferase Assays
HEK293T cells were calcium phosphate-transfected with CMV-Renilla and
either a TCF/LEF luciferase reporter construct (M50 Super 83 TOPFlash
[Veeman et al., 2003] or an NF-kB luciferase reporter) construct along with
varying amounts of FLAG-ITCH. M50 Super 83 TOPFlash was a gift from
Randall Moon (Addgene plasmid 12456). Cells were lysed in 13 passive lysis
buffer and assayed for luciferase and Renilla activities (Promega Dual-Lucif-
erase Reporter Assay System). Luciferase values were normalized to Renilla
and fold change was calculated relative to unstimulated cells in the absence
of ITCH.
Lentiviral shRNA and Retroviral RNAi-Resistant ITCH
Reconstitution/CRISPR NEMO/ Cells
A549 cells were stably transduced with ITCH shRNA lentiviral constructs in the
pLKO vector (Sigma-Aldrich). ITCH sh1 and sh2 were directed at the se-
quences 50-GCAGCAGTTTAACCAGAGATT-30 and 50-CCAGGAGAAGAAG
GTTTAGAT-30 within ITCH, respectively. ITCH shRNA knockdown was con-
firmed through western blotting after puromycin selection. ITCH sh1-resistant
FLAG-ITCH and FLAG-S687D ITCH were generated through point muta-
genesis within the pBABE (hygro)-FLAG-ITCH vector (mutagenesis primers:
forward, 50-CTTCAAGGAGCAATGCAGCAGTTCAATCAGAGATTCATTTATG
G-30; reverse, 50-CCATAAATGAATCTCTGATTGAACTGCTGCATTGCTCCTT
GAAG-30). The sh1-resistant constructs were stably transduced in the ITCH
sh1 stable cell line and selected with hygromycin. NEMO/ CRISPR cell
lines were generated via lentiviral transduction of a LentiCRISPRv2 construct
(Sanjana et al., 2014) modified to contain the guide sequence 50-
GAGCGCCCTGTTCTGAAGGC-30. lentiCRISPR v2was a gift from Feng Zhang
(Addgene plasmid 52961). Cells were selected with puromycin and then
cloned to select for colonies with validated knockout. Six validated clones
were pooled. Similarly, negative CRISPR control cells were virally transduced
with a LentiCRISPRv2 construct containing the irrelevant guide sequence 50-
CGCGATAGCGCGAATATATT-30.
qRT-PCR
RNA was isolated with RNEasy QIAGEN kit and cDNA was generated using
QIAGEN’s Quantitect Reverse Transcription kit, according to the manufac-
turer’s instructions. Real-time PCR was performed with primers generated
to detect human IL-6 (forward, 50-TCCACAAGCGCCTTCGGTCC-30; reverse,
50-GTGGCTGTCTGTGTGGGGCG-30 ), IL-8 (forward, 50-CCTGATTTCTGCAG
CTCTGTG-30; reverse, 50-CCAGACAGAGCTCTCTTCCAT-30), and GAPDH
(forward, 50-GACCTGACCTGCCGTCTA-30; reverse, 50-GTTGCTGTAGCCAAATTCGTT-30), using iQ SYBR Green Supermix (Bio-Rad). The data shown
are normalized to GAPDH.
Mice and Histology Scoring
ITCH/ mice (MRC Harwell; backcrossed over ten generations onto the
C57BL/6 mice from Jackson ImmunoResearch Laboratories) were crossed
with C57BL/6 TNFR1/ mice (Jackson ImmunoResearch Laboratories).
Lung tissue was harvested from mice at 2, 4, and 6 months of age from
each genotype and scored blindly by a board-certified anatomic pathologist
(D.W.A.). The scoring system was based on the following parameters: arteri-
olar inflammation, bronchiolar inflammation, protein, pleural inflammation,
and inducible bronchus-associated lymphoid tissue (iBALT), with a scoring
range of 0–4 for each parameter. Animal studies were performed within a spe-
cific-pathogen-free animal facility under IACUC-approved protocols, Case
Western Reserve University.
Graphs and Statistical Analyses
GraphPad Prism software was used to create graphs and perform statistical
analyses. Significance on luciferase assays and qRT-PCRwas determined us-
ing a paired Student’s t test (NF-kB, n = 3; TCF/LEF, n = 4). Significance on his-
tology scoring was determined performing multiple comparisons of one-way
ANOVA.
Structural and Sequence Analyses
Clustal W2 was used for multiple sequence alignment of protein sequences
obtained from NCBI Protein. PyMOLwas used to highlight residue S687 within
the ITCHHECT domain fromNCBI Structure (Protein Data Bank [PDB]: 3TUG).
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